Original research-Orijinal arastırma
Makaleler > Tam Makale · 2010
Yazarlar: Oya Bayındır
, Uluslararası, 2010
Özet
Aim. For prostate cancer (PCa) screening “percent free prostate specific antigen” (pfPSA) testing is used for improving test specificity of prostate specific antigen (tPSA) and is used when tPSA is between 2.5 and 10 ng/mL, according to international screening guidelines of American Urological Association (AUA), and American Cancer Society (ACS). We evaluated the number of pfPSA testing requested in practice and the concordance to PCa screening guidelines. Method. The number of pfPSA testing performed at different age groups and different tPSA levels had evaluated, in our hospital between 2004 and 2007. Result. Twenty five thousand eight hundred and forty five pfPSA tests were performed between 2004 and 2007. Only 23.7 % of men were at tPSA levels 2.5-10 ng/mL. 9.8 % of patients were under age 45 years, and 10.2 % of them were over 75 years. Conclusion. There is no real pfPSA screening consistency with screening guidelines. Laboratories, clinicians and practitioners should overview their pfPSA requests for PCa screening.